Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$416,764
+$18,083 QoQ
Shares Held
1,641
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.17%
of 13F equity value
Holder Rank
#3,877
of 4,664 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Solutions 4 Wealth, Ltd holds $1,988,038 across 2 Drug Manufacturers - General names. JNJ ranks #2 (21.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
10,026 | $1,571,274 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,641 | $416,764 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $416,764 | 1,641 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $398,681 | 1,631 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $337,535 | 1,631 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $302,420 | 1,631 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $249,593 | 1,634 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $270,982 | 1,634 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $236,309 | 1,634 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $280,525 | 1,731 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $255,487 | 1,748 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $286,956 | 1,814 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $284,326 | 1,814 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||